• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diketopiperazines as a new class of platelet-activating factor inhibitors.

作者信息

Shimazaki N, Shima I, Hemmi K, Hashimoto M

机构信息

Fujisawa Pharmaceutical Co., Ibaraki, Japan.

出版信息

J Med Chem. 1987 Oct;30(10):1706-9. doi: 10.1021/jm00393a002.

DOI:10.1021/jm00393a002
PMID:3656347
Abstract
摘要

相似文献

1
Diketopiperazines as a new class of platelet-activating factor inhibitors.二酮哌嗪作为一类新型血小板活化因子抑制剂。
J Med Chem. 1987 Oct;30(10):1706-9. doi: 10.1021/jm00393a002.
2
PAF inhibitory activity of diketopiperazines: structure-activity relationships.
Lipids. 1991 Dec;26(12):1175-8. doi: 10.1007/BF02536526.
3
Synthesis and platelet-activating factor (PAF)-antagonistic activities of trisubstituted piperazine derivatives.三取代哌嗪衍生物的合成及其血小板活化因子（PAF）拮抗活性
Chem Pharm Bull (Tokyo). 1994 Mar;42(3):551-9. doi: 10.1248/cpb.42.551.
4
Diketopiperazine derivatives, a new series of platelet-activating factor inhibitors.二酮哌嗪衍生物，一类新型血小板活化因子抑制剂。
Chem Pharm Bull (Tokyo). 1987 Aug;35(8):3527-30. doi: 10.1248/cpb.35.3527.
5
Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivatives.1,4-二取代哌嗪衍生物的合成及其血小板活化因子（PAF）拮抗活性
Chem Pharm Bull (Tokyo). 1994 Mar;42(3):541-50. doi: 10.1248/cpb.42.541.
6
2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Chem Pharm Bull (Tokyo). 1997 Oct;45(10):1659-64. doi: 10.1248/cpb.45.1659.
7
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines.
J Med Chem. 1993 Apr 16;36(8):990-1000. doi: 10.1021/jm00060a006.
8
The antagonist effects of compounds derived from khellactone on platelet-activating factor.从凯林内酯衍生的化合物对血小板活化因子的拮抗作用。
Chem Pharm Bull (Tokyo). 1988 Oct;36(10):4221-4. doi: 10.1248/cpb.36.4221.
9
Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
Arch Int Pharmacodyn Ther. 1990 Nov-Dec;308:123-36.
10
(Pyridylcyanomethyl)piperazines as orally active PAF antagonists.（吡啶基氰基甲基）哌嗪类作为口服活性血小板活化因子拮抗剂
J Med Chem. 1992 Oct 30;35(22):4118-34. doi: 10.1021/jm00100a018.

引用本文的文献

1
Solid phase organic synthesis (SPOS): a novel route to diketopiperazines and diketomorpholines.固相有机合成（SPOS）：一种合成二酮哌嗪和二酮吗啉的新途径。
Mol Divers. 1996 Feb;1(2):125-34. doi: 10.1007/BF01721328.
2
PAF inhibitory activity of diketopiperazines: structure-activity relationships.
Lipids. 1991 Dec;26(12):1175-8. doi: 10.1007/BF02536526.